Boston Scientific Corporation
BSX (NYSE)
Boston Scientific Corporation stands out as a top-rated stock for June 2026, featuring prominently on NerdWallet's best-stocks list and trading under the NYSE ticker BSX. Although the stock has experienced a steep decline with a 1-year return of -45.71%, it boasts a solid 5-year return of 37.37%. Analysts remain optimistic, with a median 12-month price target of $90.00, supported by solid ratings from firms such as Baird and BTIG.
Pros:
- Diverse product offerings in medical devices
- Strong historical performance over 10 years
Cons:
- Significant decline in stock price recently
- Increased competition in the market
Boston Scientific Corporation (BSX) may be suitable for long-term investors who can tolerate short-term volatility and are looking for growth potential in the medical devices sector. While the stock has faced significant challenges over the past year, its strong historical performance over five years and positive analyst outlook suggest it may appeal to those willing to invest based on future prospects rather than immediate returns.